Vietnam launches major RSV study in toddlers
NCT ID NCT07640581
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is observing 2,000 children under 2 years old in Ho Chi Minh City who have respiratory infections. Researchers will test for RSV, track how the virus spreads across seasons, and measure the illness's impact on families, including medical costs. No new treatments or vaccines are being tested.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help public health officials better understand RSV patterns in young children in Vietnam, potentially guiding future prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot directly improve health outcomes, and results may not apply to other regions or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 2,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Aug 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population includes children aged 0 to 24 months presenting to the outpatient or inpatient facilities of the study sites with symptoms of acute respiratory infection (ARI).
- Ages
-
0 to 24 months
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children aged 0 to \<24 months (i.e., less than two years old). * Children presenting with a diagnosis of acute respiratory infection (ARI), defined as an illness with one or more of the following symptoms: cough, rhinorrhea, sore throat, dyspnea (including wheezing, tachypnea, or apnea/increased work of breathing), sepsis (for infants aged \<6 months), and/or fever. * Children residing in the lowest administrative division (Phường / Xã) in Vietnam that is designated for the specific study site (outpatient clinic or community hospital). As patients live in the same administrative district as the healthcare facility, this will facilitate follow-up and ensure that the study results are representative of the range of severity of ARI presenting to each specific study site. * Parent or LAR provides written informed consent for their child's participation. Exclusion Criteria: * Children whose mothers received a maternal RSV vaccine during pregnancy or who have themselves received RSV-specific monoclonal antibodies (mAbs). * Children with a known non-respiratory cause for hospitalization. * Children with respiratory symptoms lasting over 14 days. * Children hospitalized elsewhere within the preceding 4 days, excluding admission to the Emergency Department. * Children already enrolled in another RSV study within the preceding 3 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute respiratory infections (ARIS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ba Ria General Hospital
NOT_YET_RECRUITINGHo Chi Minh City, Ho Chi Minh, 700000, Vietnam
-
Di An Medical Center
RECRUITINGHo Chi Minh City, Ho Chi Minh, 700000, Vietnam
-
Le Van Thinh Hospital
NOT_YET_RECRUITINGHo Chi Minh City, Ho Chi Minh, 700000, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple mask stop the flu? 2,000 volunteers put it to the test
- New surveillance study aims to spot respiratory outbreaks before they spread
- New rapid test aims to curb antibiotic overuse for common colds
- Could a single pill shorten the flu? new trial aims to find out
- Fingerstick test could help doctors skip unnecessary antibiotics
- New Finger-Prick test could slash unnecessary antibiotics in kids